MWNA
ACAD icon

Marshall Wace North America’s Acadia Pharmaceuticals ACAD Stock Holding History

Marshall Wace North America’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-9,545
Closed -$246K – 1401
2021
Q1 		$246K Sell
9,545
-418,902
-98% -$18.4M ﹤0.01% 1359
2020
Q4 		$22.9M Sell
428,447
-790,742
-65% -$39.3M 0.1% 222
2020
Q3 		$50.3M Buy
1,219,189
+1,194,767
+4,892% +$51.6M 0.32% 74
2020
Q2 		$1.18M Buy
+24,422
New +$1.17M 0.01% 718
2020
Q1 		– Sell
-31,115
Closed -$1.33M – 1178
2019
Q4 		$1.33M Buy
+31,115
New +$1.35M 0.01% 665
2018
Q3 		– Sell
-198,214
Closed -$3.03M – 889
2018
Q2 		$3.03M Buy
+198,214
New +$3.53M 0.02% 651

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return